Mode
Text Size
Log in / Sign up
N/A N=60 Randomized Double-blind Other

Local Effects of Acupuncture and Nerve Conduction Studies

Carpal Tunnel Syndrome

Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Oct 2023
Primary outcome: Primary: Change in Median Cold Detection Threshold (CDT) Post-acupuncture Compared to Pre-acupuncture When the Median Nerve is Treated — 0.73; -0.195; 0.865 JND (just noticeable difference)

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
MAC acupuncture needles (Device); Electrostimulator 6c.Pro, Pantheon Research, Venice, CA (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Oregon Health and Science University
Primary completion
May 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Median Cold Detection Threshold (CDT) Post-acupuncture Compared to Pre-acupuncture When the Median Nerve is Treated
0.73; -0.195; 0.865
PRIMARY
Change in Ulnar Cold Detection Threshold (CDT) Post-acupuncture Compared to Pre-acupuncture When the Median Nerve is Treated
0.215; 0.07; 0.375
PRIMARY
Change in Median Cold Detection Threshold (CDT) Post-acupuncture Compared to Pre-acupuncture When the Ulnar Nerve is Treated
-0.37; 0.23; 0.23
PRIMARY
Change in Ulnar Cold Detection Threshold (CDT) Post-acupuncture Compared to Pre-acupuncture When the Ulnar Nerve is Treated
-0.68; 0.30; 0.405

Summary

Thus study aims to characterize the local, nerve-specific effects of acupuncture on the median and ulnar nerves in the forearm, using nerve conduction studies and quantitative sensory testing. All participant will have carpal tunnel syndrome and the affected median nerve will be compared to the healthy ulnar nerve. Additionally, we aim to compare the local, nerve-specific effect of manual acupuncture to that of low-frequency electroacupuncture and of high-frequency electroacupuncture.

Eligibility Criteria

Inclusion Criteria

  • Presence of mild-moderate sensorimotor or sensory median neuropathy, established by pre-existing NCS/EMG study AND
  • Baseline NCS study within the past 2 years, consistent with mild-moderate median entrapment neuropathy (CTS) defined as meeting any of the 3 conditions below:
  • Prolonged distal Median sensory AND/OR motor latency
  • Reduced Median sensory nerve action potentials (SNAP) amplitude by no more than 50%
  • Amplitude of the compound muscle action potential (CMAP) recorded from APB > 50% of normal
  • Presence of neuropathy symptoms consistent with CTS for at least 3 months

Exclusion Criteria

Conditions in which acupuncture/electroacupuncture may be contraindicated:

  • Coagulopathy/ Current anti-coagulation treatment
  • Epilepsy
  • History of CAD or pacemaker insertion
  • Pregnancy
  • Presence of any skin condition in the arm, such as dermatitis, bruises, weeping skin, skin lesions, infected skin, or necrotic skin.

Conditions in which QST testing may be contraindicated:

  • Significant cognitive impairment such as diagnosis of Alzheimer's disease or Mental Retardation or any other condition interfering with alertness, attention and ability to participate in QST
  • Hospitalization for anxiety or depression in the past 3 months
  • Current psychiatric diagnoses (other than anxiety or depression)
  • Illicit drug use in the past month
  • Current EtOH abuse (> 2 drinks/day)
  • History of significant neurological disease which may affect sensation, e.g., strokes, Multiple Sclerosis, or spinal cord disorder
  • Change in neuropathy medications within the past 2 months
  • Change in opioid, benzodiazepines, SSRIs or other sedating medications in the past 2 months

Conditions, which predispose to generalized neuropathy

  • Abnormal thyroid function tests (by history)
  • Past chemotherapy treatment

Other Contraindications:

  • History of wrist or elbow fracture, past arm trauma, loss of fingers, scarring
  • History of carpal tunnel release surgery or any other surgery on the arm or shoulder
  • History of arthritis
  • Use of any investigational drugs within the previous six months

Exclusion Criteria based on NCS within the past 2 years:

  • Presence of isolated motor Median neuropathy (absence of sensory neuropathy on NCS or absence of sensory symptoms)
  • Severe neuropathy symptoms leading to inability to tolerate acupuncture or QST
  • Presence of Severe Carpal Tunnel Syndrome, defined as:
  • Absent sensory nerve action potential recorded from the second or fifth digit.
  • The amplitude of the compound muscle action potential recorded from the APB or ADM is less than 50% of normal (< 2.5 mv)
  • Presence of Ulnar neuropathy
  • Presence of Martin-Gruber anastomosis

Secondary Exclusion Criteria after WEEK 1 Baseline QST and NCS measurements:

  • Failure to comply with QST due to inattentiveness, etc
  • Hyperalgesia on QST
  • Hypoalgesia on QST
  • Inability to confirm diagnosis of mild-moderate CTS (normal NCS)
  • Inability to tolerate NCS/QST
  • Presence Severe CTS
  • Pure Motor Median Neuropathy
  • Ulnar Neuropathy
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03036657). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search